/CDT
CDT Stock - CDT Equity Inc.
Healthcare|BiotechnologyNASDAQ
$1.63-2.98%
$0.05 (-2.98%) • Dec 19
45
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.50
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.79
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CDT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.61 – $1.65
TARGET (TP)$1.87
STOP LOSS$1.50
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.75
52W High$2196.00
52W Low$1.48
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A |
| Gross Profit | $-457,000 | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A |
| Operating Income | $-15,419,000 | $-5,262,000 | $-3,160,000 | $-3,173,000 |
| Net Income | $-17,802,000 | $-535,000 | $-4,887,000 | $-3,657,000 |
| Net Margin | N/A | N/A | N/A | N/A |
| EPS | $-20.53 | $-3.60 | $-0.07 | $-1.01 |
Company Overview
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CDTBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-13.16
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | — | $-13.16 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-43.68 | — | — |
Q2 2025 | May 15, 2025 | — | $-19.79 | — | — |
Q1 2025 | Mar 28, 2025 | — | $-20.33 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-7.00 | — | — |
Q3 2024 | Aug 12, 2024 | — | $-7.00 | — | — |
Q2 2024 | May 14, 2024 | — | $-0.05 | — | — |
Q1 2024 | Mar 25, 2024 | — | $0.04 | — | — |
Q4 2023 | Nov 20, 2023 | — | $-0.80 | — | — |
Q3 2023 | Sep 30, 2023 | — | $0.06 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-1.17 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.36 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.03 | — | — |
Q2 2022 | Jun 29, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.00 | — | — |
Latest News
CDT Equity Sells Conduit Pharmaceuticals To Corvus Capital, CEO's Subsidiary, For $7M Via Stock And Pre-Funded Warrants
➖ NeutralBenzinga•Dec 12, 2025, 09:31 PM•Also:
Reported Earlier: CDT Equity Acquires Additional ~9.26 BTC For ~$1M As Part Of Ongoing Crypto Treasury Strategy; CDT's Total Bitcoin Holdings Now Stand At 17.9090111 BTC
📈 PositiveBenzinga•Oct 17, 2025, 03:37 PM•Also: , ,
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
➖ NeutralBenzinga•Oct 13, 2025, 12:55 PM
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
➖ NeutralBenzinga•Oct 10, 2025, 11:50 PM
CDT stock has given up its prior gain. CDT Equity shares were trading higher.
📉 NegativeBenzinga•Oct 9, 2025, 12:36 PM
CDT Equity Announces 1-For-8 Reverse Stock Split, Effective October 10, 2025
📉 NegativeBenzinga•Oct 9, 2025, 12:07 PM
CDT Equity shares are trading higher. The company announced a 1-for-8 reverse stock split.
➖ NeutralBenzinga•Oct 9, 2025, 12:06 PM
CDT Equity shares are trading higher after the company announced the acquisition of ~8.65 BTC for $1 million at an average price of $115,285 Per BTC.
📈 PositiveBenzinga•Sep 17, 2025, 01:49 PM
CORRECTION: CDT Equity shares are trading higher after the company announced the acquisition of ~8.65 BTC for $1 million at an average price of $115,285 Per BTC.
📈 PositiveBenzinga•Sep 17, 2025, 01:49 PM
CDT Equity shares are trading higher after the company announced the strategic acquisition of 8.65252366 for $1 million at an average price of $11,285 per share.
📈 PositiveBenzinga•Sep 17, 2025, 01:02 PM
CDT Equity Announces Strategic Purchase Of ~8.65 Bitcoin For $1M At An Average Price Of $115,285 Per BTC
➖ NeutralBenzinga•Sep 17, 2025, 12:36 PM•Also: , ,
CDT Board Authorizes Cryptocurrency-Based Treasury Reserve Strategy To Hold Part Of Its Current Balance Sheet, Diversifying Its Capital Management Approach For The Company's Assets.
📈 PositiveBenzinga•Sep 3, 2025, 12:31 PM
CDT Equity Identifies New Biological Target And Therapeutic Use For AZD1656 Through AI-Driven Drug Repurposing
📈 PositiveBenzinga•Aug 26, 2025, 12:37 PM
Frequently Asked Questions about CDT
What is CDT's current stock price?
CDT Equity Inc. (CDT) is currently trading at $1.63 per share. The stock has moved -2.98% today.
What is the analyst price target for CDT?
No analyst price targets are currently available for this stock.
What sector is CDT Equity Inc. in?
CDT Equity Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is CDT's market cap?
CDT Equity Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does CDT pay dividends?
No, CDT Equity Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCCM
Concord Medical Services Holdings Limited
$4.15
Mkt Cap: $0.0B
COCH
Envoy Medical, Inc.
$0.73
Mkt Cap: $0.0B
ENVB
Enveric Biosciences, Inc.
$5.08
Mkt Cap: $0.0B
HEPA
Hepion Pharmaceuticals, Inc.
$0.07
Mkt Cap: $0.0B
LIXT
Lixte Biotechnology Holdings, Inc.
$4.32
Mkt Cap: $0.0B
NIVF
NewGenIvf Group Limited
$0.90
Mkt Cap: $0.0B
PTPI
Petros Pharmaceuticals, Inc.
$0.01
Mkt Cap: $0.0B
WORX
SCWorx Corp.
$0.22
Mkt Cap: $0.0B
XAGE
Longevity Health Holdings Inc.
$0.43
Mkt Cap: $0.0B
ZVSA
ZyVersa Therapeutics, Inc.
$0.14
Mkt Cap: $0.0B
Explore stocks similar to CDT for comparison